ARGENX SE is 1.9x more valuable than BIOGEN INC. by market capitalization ($53.35 B vs $28.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARGX | BIIB |
|---|---|---|
| Market cap | $53.35 B | $28.73 B |
| US-listed rank | #306 | #480 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | - | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 272 | 2,690 |
ARGENX SE is 1.9x more valuable than BIOGEN INC. by market capitalization ($53.35 B vs $28.73 B).
Full pages: ARGENX SE and BIOGEN INC., or browse the full rankings.